Literature DB >> 20519229

The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetes.

Sydney C W Tang1, Violet T M Leung, Loretta Y Y Chan, Sunny S H Wong, Daniel W S Chu, Joseph C K Leung, Yiu Wing Ho, Kar Neng Lai, Lijun Ma, Steven C Elbein, Donald W Bowden, Pamela J Hicks, Mary E Comeau, Carl D Langefeld, Barry I Freedman.   

Abstract

BACKGROUND: A single-nucleotide polymorphism (SNP), rs2268388, in the acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with susceptibility to type 2 diabetic nephropathy (T2DN) in Japanese and European-American populations. Whether this association also exists in Chinese patients is unclear. Attempts at replication in small Singaporean and Korean samples were not significant.
METHODS: Eight ACACB SNPs were genotyped in 595 subjects with type 2 diabetes mellitus born in Hong Kong or southern China, 295 with advanced T2DN and 300 with long-standing diabetes lacking nephropathy. Association analyses were focused primarily on SNP rs2268388 and secondarily on flanking SNPs and haplotypes.
RESULTS: Adjusting for age, gender and diabetes duration, ACACB SNP rs2268388 was significantly associated with advanced T2DN (odds ratio = 2.39; recessive model; P = 0.0129).
CONCLUSION: These results in the Chinese replicate the association between T2DN and rs2268388, as seen in Japanese and European Americans. The ACACB gene and attendant alterations in fatty acid oxidation may play important roles in susceptibility to T2DN. Targeting this pathway may provide novel treatment options for the prevention of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519229      PMCID: PMC3108368          DOI: 10.1093/ndt/gfq303

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy.

Authors:  Masumi Kamiyama; Masaaki Kobayashi; Shin-ichi Araki; Aritoshi Iida; Tatsuhiko Tsunoda; Koichi Kawai; Masahito Imanishi; Makoto Nomura; Tetsuya Babazono; Yasuhiko Iwamoto; Atsunori Kashiwagi; Kohei Kaku; Ryuzou Kawamori; Daniel P K Ng; Torben Hansen; Peter Gaede; Oluf Pedersen; Yusuke Nakamura; Shiro Maeda
Journal:  Hum Genet       Date:  2007-08-02       Impact factor: 4.132

2.  A note on exact tests of Hardy-Weinberg equilibrium.

Authors:  Janis E Wigginton; David J Cutler; Goncalo R Abecasis
Journal:  Am J Hum Genet       Date:  2005-03-23       Impact factor: 11.025

3.  Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy.

Authors:  Atsuyuki Shimazaki; Yoshihiro Kawamura; Akio Kanazawa; Akihiro Sekine; Susumu Saito; Tatsuhiko Tsunoda; Daisuke Koya; Tetsuya Babazono; Yasushi Tanaka; Masafumi Matsuda; Koichi Kawai; Tomohiro Iiizumi; Masahito Imanishi; Toshihiro Shinosaki; Toru Yanagimoto; Minoru Ikeda; Shigeki Omachi; Atsunori Kashiwagi; Kohei Kaku; Yasuhiko Iwamoto; Ryuzou Kawamori; Ryuichi Kikkawa; Masatoshi Nakajima; Yusuke Nakamura; Shiro Maeda
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

4.  Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.

Authors:  L Abu-Elheiga; M M Matzuk; K A Abo-Hashema; S J Wakil
Journal:  Science       Date:  2001-03-30       Impact factor: 47.728

5.  Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans.

Authors:  T S Leak; P S Perlegas; S G Smith; K L Keene; P J Hicks; C D Langefeld; J C Mychaleckyj; S S Rich; J K Kirk; B I Freedman; D W Bowden; M M Sale
Journal:  Ann Hum Genet       Date:  2009-01-23       Impact factor: 1.670

6.  A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes.

Authors:  Shiro Maeda; Masa-aki Kobayashi; Shin-ichi Araki; Tetsuya Babazono; Barry I Freedman; Meredith A Bostrom; Jessica N Cooke; Masao Toyoda; Tomoya Umezono; Lise Tarnow; Torben Hansen; Peter Gaede; Anders Jorsal; Daniel P K Ng; Minoru Ikeda; Toru Yanagimoto; Tatsuhiko Tsunoda; Hiroyuki Unoki; Koichi Kawai; Masahito Imanishi; Daisuke Suzuki; Hyoung Doo Shin; Kyong Soo Park; Atsunori Kashiwagi; Yasuhiko Iwamoto; Kohei Kaku; Ryuzo Kawamori; Hans-Henrik Parving; Donald W Bowden; Oluf Pedersen; Yusuke Nakamura
Journal:  PLoS Genet       Date:  2010-02-12       Impact factor: 5.917

7.  Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms.

Authors:  Nobue Tanaka; Tetsuya Babazono; Susumu Saito; Akihiro Sekine; Tatsuhiko Tsunoda; Masakazu Haneda; Yasushi Tanaka; Tomoaki Fujioka; Kohei Kaku; Ryuzou Kawamori; Ryuichi Kikkawa; Yasuhiko Iwamoto; Yusuke Nakamura; Shiro Maeda
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

8.  Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy.

Authors:  Marcus G Pezzolesi; Pisut Katavetin; Masahiko Kure; G David Poznik; Jan Skupien; Josyf C Mychaleckyj; Stephen S Rich; James H Warram; Andrzej S Krolewski
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

  8 in total
  19 in total

Review 1.  Insights into the genetic architecture of diabetic nephropathy.

Authors:  Nicholette D Palmer; Barry I Freedman
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

2.  The effect of ACACB cis-variants on gene expression and metabolic traits.

Authors:  Lijun Ma; Ashis K Mondal; Mariana Murea; Neeraj K Sharma; Anke Tönjes; Kurt A Langberg; Swapan K Das; Paul W Franks; Peter Kovacs; Peter A Antinozzi; Michael Stumvoll; John S Parks; Steven C Elbein; Barry I Freedman
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

Review 3.  The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.

Authors:  Tingting Li; Yun Shi; Jieyun Yin; Qin Qin; Sheng Wei; Shaofa Nie; Li Liu
Journal:  Int Urol Nephrol       Date:  2014-09-28       Impact factor: 2.370

Review 4.  Genome-wide association studies of albuminuria: towards genetic stratification in diabetes?

Authors:  Cristian Pattaro
Journal:  J Nephrol       Date:  2017-09-16       Impact factor: 3.902

5.  Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2.

Authors:  Kapil Kampe; Jonas Sieber; Jana Marina Orellana; Peter Mundel; Andreas Werner Jehle
Journal:  Am J Physiol Renal Physiol       Date:  2013-12-11

Review 6.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

Review 7.  Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications.

Authors:  Mariana Murea; Lijun Ma; Barry I Freedman
Journal:  Rev Diabet Stud       Date:  2012-05-10

8.  Protein kinase C-β gene variants and type 2 diabetes-associated kidney failure: What can we learn from gene association studies in diabetic nephropathy?

Authors:  Barry I Freedman; Donald W Bowden; Mariana Murea
Journal:  Am J Kidney Dis       Date:  2010-12-13       Impact factor: 8.860

Review 9.  Structure and function of biotin-dependent carboxylases.

Authors:  Liang Tong
Journal:  Cell Mol Life Sci       Date:  2012-08-07       Impact factor: 9.261

10.  ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes.

Authors:  Viral N Shah; Balneek Singh Cheema; Rajni Sharma; Madhu Khullar; Harbir Singh Kohli; Tarunveer Singh Ahluwalia; Viswanathan Mohan; Anil Bhansali
Journal:  Mol Cell Biochem       Date:  2012-10-19       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.